Form 4: Director Karen May Exercises Solventum RSU Awards

Director Karen J. May acquired 3,403 shares of Solventum Corp common stock through the settlement of vested restricted stock units.

Summary

• Director Karen J. May acquired 3,403 shares of Solventum Corp (SOLV) common stock on April 30, 2026.
• The acquisition resulted from the settlement of 3,403 restricted stock units (RSUs) that were fully vested.
• Following this transaction, Karen J. May holds a total of 8,947 shares of common stock directly.
• The transaction was executed at a price of $0 per share as part of an equity compensation settlement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative settlement of director compensation rather than a market-moving event.

Positives

• Director maintains a direct equity stake in the company, aligning interests with shareholders.
• The transaction reflects the vesting of previously granted equity compensation.

Negatives

• None identified; this is a routine equity settlement.

Risks

• None identified; this is a standard administrative filing regarding director compensation.

Future Outlook

Not applicable; this is a historical record of an equity transaction.

Industry Context

StockSavvy.ai notes that routine equity settlements for directors are standard corporate governance practices and do not typically signal changes in company strategy or market outlook.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for director equity compensation.
• The use of RSUs as a component of director compensation is consistent with industry practices for large-cap healthcare and technology firms.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation settlement.

Next Steps

• None identified.

Key Dates

Keywords

Solventum, SOLV, Form 4, Insider Trading, Director Compensation, Restricted Stock Units